IOVA vs OGN · rev $170.7M vs P/E 3.4, rev $3.02B
Iovance Biotherapeutics Inc (IOVA) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported IOVA revenue for 2026-06-30 was $170.7M. Net income was -$126.4M. IOVA currently screens at market cap $1.89B.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
IOVA currently screens at market cap $1.89B. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the IOVA and OGN stock pages for the full models.
Not investment advice.